The Application and Transformation Challenges of Stem Cell Technology in the Repair of Articular Cartilage Injuries
DOI:
https://doi.org/10.54097/a0zavz49Keywords:
Stem Cell Technology, Articular Cartilage Injuries, Repair.Abstract
The articular cartilage lacks blood vessels, nerves and lymphatic vessels. If damaged, it is difficult to achieve effective endogenous repair. Focal defects often progress to osteoarthritis. Traditional treatments such as microfracture surgery and autologous chondrocyte transplantation can alleviate related symptoms, but the repaired tissues are mostly fibrocartilage, which has a gap in mechanical performance compared to natural transparent cartilage. Moreover, they may face issues such as secondary surgeries, donor site damage, and insufficient long-term durability. Stem cells, due to their proliferative potential, multi-directional differentiation ability and microenvironmental regulatory function, are currently an important research direction for cartilage regeneration. This article systematically reviews the research progress of different stem cells in joint cartilage repair and summarizes related mechanisms such as directed differentiation, paracrine regulation, immune regulation and anti-apoptosis protection. In terms of clinical evidence-based application, data on mesenchymal stem cells (MSCs) is the most sufficient, which can improve pain, function and cartilage volume; iPSCs-derived cartilage shows advantages in long-term matrix synthesis and anti-hypertrophic apoptosis. However, heterogeneity of efficacy, lack of efficacy indicators, uncertain regulatory pathways, bottlenecks in manufacturing scale-up and problems of graft integration and durability still restrict clinical translation. Further exploration is still needed in the future.
Downloads
References
[1] Golightly YM, Sheree SS, Allen KD. Epidemiology of osteoarthritis: 2026 update of the evidence. Osteoarthritis Cartilage. 2026 Oct;34(10):1412-1424. DOI: https://doi.org/10.1016/j.joca.2026.06.014
[2] Zhang X, Huang C, Hu Z, Tan Y, Wang P, Zhu L, Kang J. Global, regional, and country-specific lifetime risks of osteoarthritis, 1990-2021: a systematic analysis for the global burden of disease study 2021. Glob Health Res Policy. 2025 Jul 22;10(1):29. DOI: https://doi.org/10.1186/s41256-025-00419-9
[3] Wang Lin, Tang Ao, Peng Bo. Research Progress on the Improvement of Cartilage Injury by Exosomes from Adipose-Derived Mesenchymal Stem Cells [J]. Advances in Physiology Research, 2025, 56(4): 395-400.
[4] Qin S, Zhang A, Duan L, Lin F, Zhao M. Exosomes Extracted from Human Umbilical Cord MSCs Contribute to Osteoarthritic Cartilage and Chondrocytes Repair Through Enhancing Autophagy While Suppressing the Wnt/β-Catenin Pathway. Tissue Eng Regen Med. 2025 Jul;22(5):719-733. DOI: https://doi.org/10.1007/s13770-025-00716-x
[5] Hu Y, Cheng P, Jia L, Hao X, Ding G, Han M, Fan J, Lu W, Zhou C, Luo Z, Yang L. Extracellular vesicles originating from induced pluripotent stem cell-derived chondrocytes facilitate the regeneration of osteoarthritic cartilage. J Orthop Translat. 2026 Jan 10; 56:101035. DOI: https://doi.org/10.1016/j.jot.2025.101035
[6] Nam Y, Park N, Choi J, Lee K, Choi SH, Kim JW, Choi S, Hong CP, Lee J, Jung JY, Oh SN, Rim YA, Ju JH. Clinical-grade iPSC-derived chondrogenic micropellets for treating advanced cartilage defects. Sci Adv. 2025 Dec 19; 11(51): eadw4911. DOI: https://doi.org/10.1126/sciadv.adw4911
[7] Jee CSY, Ramlan A, Mohd Ali R, Khairuddin NH, Chen HC, Dawam A, Saw YC, Saw KY. Autologous Peripheral Blood Stem Cells with Adjuvant Hyaluronic Acid Enhance Cartilage Repair After Subchondral Drilling in a Sheep Model. Arthrosc Sports Med Rehabil. 2025 Jul 8; 7(5): 101217. DOI: https://doi.org/10.1016/j.asmr.2025.101217
[8] Pan X, Li X, Zhang L, Wu F, Zhang Q, Xu S, Shen C, Liang J, Pan R. Umbilical cord mesenchymal stem cells relieve osteoarthritis in rats through immunoregulation and inhibition of chondrocyte apoptosis. Sci Rep. 2023 Sep 11; 13(1): 14975. DOI: https://doi.org/10.1038/s41598-023-42349-x
[9] Chu H, Zhang S, Zhang Z, Yue H, Liu H, Li B, Yin F. Comparison studies identify mesenchymal stromal cells with potent regenerative activity in osteoarthritis treatment. NPJ Regen Med. 2024 Apr 1; 9(1): 14. DOI: https://doi.org/10.1038/s41536-024-00358-y
[10] Li Y, Fu T, Yu W, Wen H, Wang Z, Lyu Z, Wen X, Ba T, Chen Z, Shan K, Li N. Mesenchymal stem cells and extracellular vesicles for knee osteoarthritis: clinical application, mechanism exploration and prospect. Stem Cell Res Ther. 2025 Nov 23; 16(1): 688. DOI: https://doi.org/10.1186/s13287-025-04783-8
[11] Koelling S, Kruegel J, Irmer M, Path JR, Sadowski B, Miro X, Miosge N. Migratory chondrogenic progenitor cells from repair tissue during the later stages of human osteoarthritis. Cell Stem Cell. 2009 Apr 3; 4(4): 324-35. DOI: https://doi.org/10.1016/j.stem.2009.01.015
[12] Zhang M, Ni S, Ng L, Zhou M, Zhang J, Tao N, Nath Varma S, Ivanova A, Hargunani R, Du Y, Liu C. Exploring the effectiveness and safety of stem cell therapy for repair of cartilage defects: a meta-analysis of randomized controlled trials. Front Cell Dev Biol. 2026 Aug 7; 14: 1880031. DOI: https://doi.org/10.3389/fcell.2026.1880031
[13] Md Yusoff BAH, Mohamad N, Chin SP, Ramlan MN, Zool Kipele MS, Saffery NSI, Mohd Nasir NA, Mohd Don AF, Lai SK, Hussin H, Yakop MF, Abdul Wahid SF, Cheong SK. Cytopeutics umbilical cord-derived mesenchymal stem cells are associated with earlier clinical improvement compared to bone marrow aspirate concentrate with scaffold in knee cartilage injury: A Phase 1 feasibility and Phase 2 randomized controlled trial. Med J Malaysia. 2026 Mar; 81(2): 234-245.
[14] Lu Y, Kats ER, Hines SE, Shang J, Kamijo S, Liu JJ, Liu S, Hogan MV, Lin H. Long-term evaluation of human iPSC-derived cartilage for repairing chondral defects. NPJ Regen Med. 2025 Dec 25; 11(1): 3. DOI: https://doi.org/10.1038/s41536-025-00447-6
[15] Kamaraj A, Kyriacou H, Seah KTM, Khan WS. Use of human induced pluripotent stem cells for cartilage regeneration in vitro and within chondral defect models of knee joint cartilage in vivo: a Preferred Reporting Items for Systematic Reviews and Meta-Analyses systematic literature review. Cytotherapy. 2021 Aug; 23(8): 647-661. DOI: https://doi.org/10.1016/j.jcyt.2021.03.008
[16] Neefjes M, Housmans BAC, van Beuningen HM, Vitters EL, van den Akker GGH, Welting TJM, van Caam APM, van der Kraan PM. Prediction of the Effect of the Osteoarthritic Joint Microenvironment on Cartilage Repair. Tissue Eng Part A. 2022 Jan; 28(1-2): 27-37. DOI: https://doi.org/10.1089/ten.tea.2021.0051
[17] Maroun G, Brondello JM, Pers YM. Strategies to overcome the full potential of mesenchymal stromal cells (MSCs) for the treatment of osteoarthritis and cartilage regeneration. Joint Bone Spine. 2026 May 12; 93(5): 106074. DOI: https://doi.org/10.1016/j.jbspin.2026.106074
[18] Tor JQ, Le QB, Ezhilarasu H, Chan WW, Choudhury D. Advancements and regulations of biomanufacturing cell-based cartilage repair therapies. Trends Biotechnol. 2025 Apr; 43(4): 738-741. DOI: https://doi.org/10.1016/j.tibtech.2024.09.016
[19] McGowan KB, Stiegman G. Regulatory Challenges for Cartilage Repair Technologies. Cartilage. 2013 Jan; 4(1): 4-11. DOI: https://doi.org/10.1177/1947603512460756
[20] Amorim PA, Agten H, Vermeulen M, Van Vlierberghe S, Geris L, Bloemen V. Novel GelMA/GelMA-AEMA Hydrogel Blend with Enhanced Printability as a Carrier for iPSC-Derived Chondrocytes In Vitro. Gels. 2025 Sep 2; 11(9): 698. DOI: https://doi.org/10.3390/gels11090698
[21] Boushell MK, Hung CT, Hunziker EB, Strauss EJ, Lu HH. Current strategies for integrative cartilage repair. Connect Tissue Res. 2017 Sep; 58(5): 393-406. DOI: https://doi.org/10.1080/03008207.2016.1231180
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

